Towards Cancer Patient Empowerment for Optimal Use of Antithrombotic Therapy at the End of Life

Informations projet

SERENITY

N° de convention de subvention: 101057292

DOI

10.3030/101057292

Date de signature de la CE 24 Mai 2022

Date de début 1 Octobre 2022

Date de fin 30 Septembre 2027

Financé au titre de

• Health

Coût total

€ 4 483 532,50

Contribution de l’UE

€ 4 483 530,50

Coordonné par

ACADEMISCH ZIEKENHUIS LEIDEN
Netherlands

CORDIS fournit des liens vers les livrables publics et les publications des projets HORIZON.

Les liens vers les livrables et les publications des projets du 7e PC, ainsi que les liens vers certains types de résultats spécifiques tels que les jeux de données et les logiciels, sont récupérés dynamiquement sur OpenAIRE .

Livrables

Documents, reports (2)

Midterm progress report on realist review

The midterm progress report will summarise the fundings half way the duration of this particular study. The final manuscript will be ready for submission by month 12. The results of the review are used to inform the creators of the shared decision support tool(WP5) as well as the methodology for the RCT (WP6).

Report on findings of the realist review on PROSPERO

This report will summarise the findings of the realist review. The results of the review are used to inform the creators of the shared decision support tool (WP5) as well as the methodology for the RCT (WP6).

Websites, patent fillings, videos etc. (1)

Project website and logo

Both a project logo and website will be designed as described in section 2.2 and launched within the first 3 months of the project.

Publications

Peer reviewed articles (10)

Use of antithrombotic therapy and the risk of cardiovascular outcomes and bleeding in cancer patients at the end of life: a Danish nationwide cohort study

Auteurs: Mette Søgaard, Marie Ørskov, Martin Jensen, Jamilla Goedegebuur, Eva K. Kempers, Chantal Visser, Eric C.T. Geijteman, Denise Abbel, Simon P. Mooijaart, Geert-Jan Geersing, Johanneke Portielje, Adrian Edwards, Sarah J. Aldridge, Ashley Akbari, Anette A. Højen, Frederikus A. Klok, Simon Noble, Suzanne Cannegieter, Anne Gulbech Ording
Publié dans: Journal of Thrombosis and Haemostasis, Numéro 23, 2025, ISSN 1538-7836
Éditeur: Elsevier BV
DOI: 10.1016/J.JTHA.2024.09.023

Discontinuation of Anticoagulants and Occurrence of Bleeding and Thromboembolic Events in Vitamin K Antagonist Users with a Life-limiting Disease

Auteurs: Eva Kempers, Chantal Visser, Eric Geijteman, Jamilla Goedegebuur, Johanneke Portielje, Mette Sogaard, Anne Gulbech Ording, Carline van den Dries, Denise Abbel, Geert-Jan Geersing, Sarah Aldridge, Kate Lifford, Ashley Akbari, Sjef van de Leur, Melchior Nie
Publié dans: Thrombosis and Haemostasis, 2025, ISSN 0340-6245
Éditeur: Schattauer
DOI: 10.1055/A-2524-5334

“Who am I to say that I'm not going to take it”: patient perspectives on decisions about antithrombotic therapy in the context of advanced cancer

Auteurs: Elin Baddeley, Carme Font, Isabelle Mahé, Michelle Edwards, Stephanie Sivell, Kate J. Lifford, Victoria Mailen Arfuch, Nuri Coma-Auli, Mette Søgaard, Helle Enggaard, Hélène Helfer, Nassima Si Mohammed, Kathy Seddon, Mark Pearson, Simone P. Mooijaart, Sebastian Szmit, F.A. Klok, Simon Noble, Anette Arbjerg Højen
Publié dans: Thrombosis Research, Numéro 253, 2025, ISSN 0049-3848
Éditeur: Elsevier BV
DOI: 10.1016/J.THROMRES.2025.109399

Anti‐thrombotic therapy in patients with cancer at the end of life and associated clinical outcomes: A cohort study using population‐linked routinely collected data

Auteurs: Sarah J. Aldridge, Ashley Akbari, Adrian Edwards, Kate J. Lifford, Denise Abbel, Suzanne Cannegieter, Jamilla Goedegebuur, Eva K. Kempers, Mette Søgaard, Chantal Visser, Geert‐Jan Geersing, Marieke J. H. Kruip, Anne Gulbech Ording, Carline van den Dries, Eric C. T. Geijteman, Erik Klok, Isabelle Mahé, Simon P. Mooijaart, Sebastian Szmit, Simon Noble
Publié dans: British Journal of Haematology, 2025, ISSN 0007-1048
Éditeur: Wiley
DOI: 10.1111/BJH.70032

Thrombosis Research

Auteurs: J, Goedegebuur; D, Abbel; F A, Klok; S I R, Noble
Publié dans: Scientia, 2023, ISSN 0049-3848
Éditeur: Pergamon Press
DOI: 10.1016/j.thromres.2023.05.008

Quality of vitamin K antagonist treatment during the last year of life

Auteurs: Chantal Visser, Eva K. Kempers, Jamilla Goedegebuur, Denise Abbel, Sarah J. Aldridge, Adrian Edwards, Michelle Edwards, Geert‐Jan Geersing, Anne Gulbech Ording, Sjef J. C. M. van de Leur, Kate J. Lifford, Isabelle Mahé, Simon P. Mooijaart, Melchior C. Nierman, Johanneke E. A. Portielje, Mette Søgaard, Sebastian Szmit, Nynke M. Wiersma, Simon I. R. Noble, Frederikus A. Klok, Qingui Chen, Suzanne C. Cannegieter, Eric C. T. Geijteman, Marieke J. H. A. Kruip, null null
Publié dans: HemaSphere, Numéro 9, 2025, ISSN 2572-9241
Éditeur: Wiley
DOI: 10.1002/HEM3.70135

Discontinuation of Anticoagulants and Occurrence of Bleeding and Thromboembolic Events in Vitamin K Antagonist Users with a Life-limiting Disease

Auteurs: Eva K. Kempers, Chantal Visser, Eric C. T. Geijteman, Jamilla Goedegebuur, Johanneke E. A. Portielje, Mette Søgaard, Anne Gulbech Ording, Carline van den Dries, Denise Abbel, Geert-Jan Geersing, Sarah J. Aldridge, Kate J. Lifford, Ashley Akbari, Sjef J. C. M. van de Leur, Melchior C. Nierman, Isabelle Mahé, Simon P. Mooijaart, Sebastian Szmit, Michelle Edwards, Simon I. R. Noble, Frederikus A. Klok, Qingui Chen, Suzanne C. Cannegieter, Marieke J. H. A. Kruip, null null
Publié dans: Thrombosis and Haemostasis, 2025, ISSN 0340-6245
Éditeur: Georg Thieme Verlag KG
DOI: 10.1055/A-2524-5334

Understanding European patterns of deprescribing antithrombotic medication during end-of-life care in patients with cancer

Auteurs: E.S.L. Martens, D. Becker, C. Abele, D. Abbel, W.P. Achterberg, J.J. Bax, L. Bertoletti, M.E. Edwards, C. Font, A. Gava, J. Goedegebuur, A.A. Højen, M.V. Huisman, M.J.H.A. Kruip, I. Mahé, S.P. Mooijaart, M. Pearson, K. Seddon, S. Szmit, S.I.R. Noble, F.A. Klok, S.V. Konstantinides
Publié dans: Thrombosis Research, Numéro 245, 2024, ISSN 0049-3848
Éditeur: Elsevier BV
DOI: 10.1016/j.thromres.2024.109205

Involving patients and the public in cancer associated thrombosis research: A strategy for success

Auteurs: Michelle Edwards, Kathy Seddon, Elin Baddeley, Anne Gulbech Ording, Mark Pearson, Isabelle Mahe, Simon Mooijaart, Frederikus A. Klok, Simon I.R. Noble
Publié dans: Thrombosis Update, Numéro 18, 2025, ISSN 2666-5727
Éditeur: Elsevier BV
DOI: 10.1016/j.tru.2024.100196

Shared decision-making and deprescribing to support anti-thrombotic therapy (dis)continuance for persons living with cancer in their last phase of life: A realist synthesis

Auteurs: Justin Jagosh, Mark Pearson, Sarah Greenley, Anthony Maraveyas, Gamze Keser, Fliss E. M. Murtagh, Simon Noble, Michelle Edwards, Adrian Edwards, Anette Arbjerg Højen, Kathy Seddon, Frederikus A. Klok, Simon P. Mooijaart, Eric C. T. Geijteman, Miriam J. Johnson
Publié dans: PLOS Medicine, Numéro 22, 2025, ISSN 1549-1676
Éditeur: Public Library of Science (PLoS)
DOI: 10.1371/JOURNAL.PMED.1004663